表观遗传学在角膜健康与疾病中的作用
表观遗传学通过组蛋白修饰、DNA甲基化和miRNA在不改变DNA序列的情况下调控基因表达,参与角膜炎症、伤口愈合、纤维化和新生血管等病理过程,并可被靶向以逆转角膜病变和开发干预疗法,但当前对其导致角膜异常和疾病的理解仍有限。
要点
- 表观遗传修饰通过改变染色质可及性调控基因表达,不改变DNA序列。
- 表观遗传修饰可调控角膜透明度、功能及炎症、伤口愈合、纤维化和新生血管等病理过程。
- 表观遗传修饰可被靶向以逆转角膜病理并开发干预疗法,但当前理解有限。
核心结论
- 表观遗传学在角膜健康与疾病中起重要作用,针对表观遗传修饰的干预有望逆转角膜病理并开发疗法,但当前理解有限。
研究设计与样本
- 综述,总结表观遗传学改变在角膜发病机制中的作用及潜在治疗靶点。
主要发现
- 表观遗传修饰通过组蛋白修饰、DNA甲基化和miRNA调控基因表达,参与角膜炎症、伤口愈合、纤维化和新生血管等病理过程。
临床怎么用
- 原文未据此给出推荐。
局限性
- 当前对表观遗传修饰如何导致角膜异常和疾病的理解有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Epigenetics plays a vital role in corneal health and diseases. Epigenetic changes regulate the expression of genes by altering the accessibility of chromatin via histone modifications, DNA methylation and miRNAs without altering DNA sequence. Ocular trauma and infections are common causes of corneal damage, vision impairment, and mono/bilateral blindness worldwide. Mounting literature shows that epigenetic modifications can modulate corneal clarity, function, and pathogenesis including inflammation, wound healing, fibrosis, and neovascularization. Additionally, epigenetic modifications can be targeted to reverse corneal pathologies and develop interventional therapies. However, current understanding on how epigenetic modifications lead to corneal abnormalities and diseases is limited. This review provides in-depth knowledge and mechanistic understanding of epigenetics alterations in corneal pathogenesis, and information on potential epigenetic targets for treatment of corneal diseases.
引用
- Sood S, Tiwari A, Sangwan J, et al. Role of epigenetics in corneal health and disease. Prog Retin Eye Res. 2024. PMID: 39547455. doi:10.1016/j.preteyeres.2024.101318
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。